To characterize how gluten-specific CD4+ T cells and celiac disease-associated CD8+ and γδ+ T cells change phenotypically in treated celiac disease patients upon gluten exposure, and to identify potential markers for T-cell-directed therapy. The gene discussed is CD8A; the disease is celiac disease.